Last Updated:
Name Designation Appointment Date Status
Ritika Anil Kumar

Appointed as Director since September 2018

Director 27-Sep-2018 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Navakumar Narayanan

Appointed as Managing Director since December 2010

Managing Director 08-Dec-2010 Current
Sudhakara Reddy Dodla

Appointed as Director since July 2018

Director 20-Jul-2018 Current

People Timeline

Explore the timeline of key personnel in Nark Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address 28/1270, Kezhupilly Cross Road Kadavanthra, Ernakulam Kerala, 682020, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Nark Pharmaceuticals Private Limited?
You can contact Nark Pharmaceuticals Private Limited through their registered address at 28/1270, Kezhupilly Cross Road Kadavanthra, Ernakulam Kerala, 682020, India, or via their website at narkpharmaceuticals.com. Social media links are also provided where applicable.
Who are the current directors of Nark Pharmaceuticals Private Limited?
The current directors of Nark Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • RITIKA ANIL KUMAR
  • NAVAKUMAR NARAYANAN
  • SUDHAKARA REDDY DODLA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available